

Scroll through any fitness forum, Reddit thread, or TikTok comment section and you will find people talking about peptides for weight loss. Some swear by obscure compounds with names like BPC-157 or ipamorelin. Others mention semaglutide in the same breath, as if all these substances belong to the same category.
In a sense, they do. GLP-1 medications like semaglutide and tirzepatide are peptides. But not all peptides are GLP-1s, and most peptides being sold for fat loss have never been tested in proper clinical trials.
If you have been researching peptides in Singapore and struggling to separate the science from the hype, you are not alone. The terminology is confusing, the marketing is aggressive, and the law is stricter here than in many other countries. Some of these substances can get you results. Others can get you a fine, a health scare, or both.
Below, we cover which peptides actually work for weight loss, which ones to avoid, what Singapore law says, and how to get the evidence-based options through a licensed clinic.
Peptides are short chains of amino acids, typically between 2 and 50 amino acids linked together. They are smaller than proteins but made of the same building blocks. Your body produces thousands of peptides naturally. They act as signalling molecules, telling cells and organs what to do.
Insulin, for example, is a peptide. It was the first therapeutic peptide ever used in medicine, and it has been saving lives since the 1920s. Oxytocin, the hormone involved in bonding and childbirth, is a peptide. So are many of your gut hormones, including the one that controls appetite: glucagon-like peptide-1, or GLP-1.
In recent years, the word "peptides" has become a catch-all term in fitness and weight loss communities. The problem is that it groups together substances with wildly different levels of evidence. Some peptides have been through rigorous clinical trials involving tens of thousands of participants. Others have been studied only in rats, or not at all.
When someone says they are using "peptides for fat loss," the first question should always be: which one?
The only peptides with strong clinical evidence for weight loss are GLP-1 receptor agonists. These are prescription medications that mimic the action of your body's own GLP-1 hormone. The three with the most data are semaglutide, tirzepatide, and liraglutide.
A quick comparison:
| Medication | Type | Key trial | Mean weight loss | Dosing |
|---|---|---|---|---|
| Semaglutide (Wegovy) | GLP-1 agonist | STEP 1 | 14.9% in 68 weeks | Weekly injection |
| Tirzepatide (Mounjaro/Zepbound) | GLP-1 + GIP dual agonist | SURMOUNT-1 | Up to 22.5% in 72 weeks | Weekly injection |
| Liraglutide (Saxenda) | GLP-1 agonist | SCALE | 8.0% in 56 weeks | Daily injection |
These are not fringe substances. Semaglutide has been tested across multiple large-scale trials including the STEP programme and the 17,604-patient SELECT cardiovascular outcomes trial. Tirzepatide's SURMOUNT-1 trial enrolled over 2,500 people, with 39.7% of those on the highest dose losing 25% or more of their body weight. Liraglutide has been used clinically since 2010.
No other peptide comes close to this level of evidence for weight loss.
If GLP-1 medications are the proven peptides, what about the rest? Several peptides are marketed heavily in fitness, bodybuilding, and biohacker circles for fat loss, muscle gain, and recovery. The most common include:
The problem with grey-market peptides goes beyond weak evidence. These substances are typically manufactured in unregulated labs, sold through online suppliers, and shipped without any quality control. You do not know the purity, the dose, or whether the vial actually contains what the label says.
Australia's Therapeutic Goods Administration has warned that peptide products purchased online frequently contain incorrect doses, contamination, or entirely different compounds than what the label claims.
One grey-market product deserves special mention: compounded semaglutide. These are versions of semaglutide made by compounding pharmacies, often marketed as a cheaper alternative to branded Wegovy or Ozempic. They look legitimate. They use the same drug name. But they are not the same product.
Compounded semaglutide is not manufactured to the same standards as approved medications. The US FDA has issued multiple warnings about adverse events linked to compounded semaglutide, including reports of incorrect dosing and contamination. In Singapore, selling compounded semaglutide without HSA approval is illegal.
Singapore's Health Sciences Authority does not take a light touch with unregulated health products. In 2023 alone, HSA prosecuted 16 individuals and removed over 12,000 illegal online listings for health products. During Operation Pangea XVI, a global enforcement effort, HSA removed over 4,600 listings and seized more than 60,000 units of illegal health products from Singapore-based sellers. Penalties can include fines of up to S$20,000 and prison terms of up to 12 months.
The legal status of peptides in Singapore depends entirely on which peptide you are talking about.
Prescription GLP-1 medications (legal with a doctor): Semaglutide (Wegovy, Ozempic, Rybelsus), tirzepatide (Mounjaro), and liraglutide (Saxenda) are all registered with the HSA and available by prescription. When prescribed by a licensed doctor after proper medical assessment, these are fully legal. You can obtain them through clinics, hospitals, or licensed telehealth providers.
Grey-market peptides (illegal to sell without HSA approval): Substances like BPC-157, CJC-1295, ipamorelin, and AOD 9604 are not approved by the HSA. Selling them in Singapore without approval is an offence under the Health Products Act. Importing them for personal use is a legal grey area, but the products themselves carry significant health risks due to the lack of quality control.
Compounded semaglutide (illegal without HSA approval): Selling non-HSA-approved versions of semaglutide is an offence, regardless of whether the compound name matches an approved drug.
Penalties: Under the Healthcare Services Act (HCSA), offences related to unapproved health products can result in fines of up to S$20,000, imprisonment of up to 12 months, or both. MOH Circular 87/2024, issued in November 2024, specifically targeted telehealth companies promoting prescription medications without proper safeguards.
The safest path is straightforward: see a licensed doctor, get a proper assessment, and use an HSA-approved medication.
GLP-1 receptor agonists mimic your body's own GLP-1 hormone, which your gut releases after eating. When you take a GLP-1 medication, it activates receptors in your brain and digestive system:
Appetite suppression: GLP-1 acts on the hypothalamus, your brain's appetite control centre. It activates neurons that signal fullness and quiets the ones that drive hunger. The result is a genuine reduction in how much you want to eat, not a white-knuckle exercise in willpower.
Reduced food noise: Many people on GLP-1 medications say the biggest change is not eating less, but thinking about food less. The constant mental chatter about what to eat, when to eat, and whether you have eaten too much gets quieter. This phenomenon, known as food noise, is one of the most reported benefits.
Slower gastric emptying: GLP-1 slows the rate at which food leaves your stomach, which means you feel physically fuller for longer after meals.
This is why GLP-1 peptides work when diets fail. Diets ask you to override your biology with willpower. GLP-1 medications change the biology itself. Your hunger signals quiet down. Fullness lasts longer. The mental battle with food eases.
Research is also advancing quickly. Next-generation peptides in development include retatrutide (a triple agonist targeting GLP-1, GIP, and glucagon receptors, with 28.7% weight loss in Phase 3), survodutide (a dual GLP-1 and glucagon agonist), and amycretin (a single molecule hitting both GLP-1 and amylin pathways). None are available yet, but they represent the direction the science is heading.
If you are considering GLP-1 peptide treatment in Singapore, these are your current options.
Most people can expect to lose 10-20% of their body weight over 6 to 12 months. In the STEP 1 trial, participants on semaglutide lost an average of 14.9% of their body weight over 68 weeks. In SURMOUNT-1, participants on the highest dose of tirzepatide lost an average of 22.5% over 72 weeks.
Results vary based on individual factors including starting weight, adherence to treatment, and lifestyle changes made alongside medication.
The most common side effects are gastrointestinal: nausea, occasional vomiting, diarrhoea, and constipation. These are typically mild to moderate and most pronounced during the dose escalation phase. Starting at a low dose and increasing gradually, which is standard practice, helps most people manage these effects.
At Trimly, GLP-1 treatment costs $350-650 per month. That is all-in pricing: medication, doctor consultations, and ongoing follow-up included. No hidden consult fees.
Ready to find out if GLP-1 peptide treatment is right for you?
Book ConsultationThe most effective peptides for weight loss are prescription GLP-1 medications. Tirzepatide currently has the strongest trial data, with up to 22.5% weight loss in SURMOUNT-1. Semaglutide follows closely at 14.9% in STEP 1. Both are available in Singapore through licensed clinics. No grey-market peptide has comparable evidence.
Prescription GLP-1 peptides (semaglutide, tirzepatide, liraglutide) have been tested in trials involving tens of thousands of participants, and their safety profiles are well documented. They are safe when prescribed by a doctor who assesses your medical history. Grey-market peptides like BPC-157 or ipamorelin have not been through rigorous safety testing and may contain unknown contaminants.
You cannot legally buy prescription peptides online without a doctor's prescription. However, you can access them through licensed telehealth clinics. Trimly offers online consultations followed by home delivery of prescribed medications. Buying unregulated peptides from overseas websites is risky both legally and medically.
Ozempic is a peptide. Specifically, it contains semaglutide, a synthetic peptide that mimics the GLP-1 hormone. The confusion comes from "peptides" being used loosely online to mean grey-market research chemicals. Ozempic and Wegovy are prescription peptides with extensive clinical trial data and regulatory approval.
Prescription GLP-1 peptides at Trimly cost $350-650 per month, which includes medication, doctor consultations, and follow-up care. Grey-market peptides may appear cheaper upfront but carry hidden costs: uncertain purity, no medical supervision, potential legal consequences, and health risks if something goes wrong.
The word "peptides" covers a lot of ground. It includes rigorously tested prescription medications and untested grey-market compounds in the same breath. That ambiguity is what makes the landscape confusing and, in some cases, dangerous.
Three things are clear:
GLP-1 peptide treatment is available now in Singapore through licensed telehealth clinics. If you have been researching peptides for weight loss and want to try the approach that is actually backed by science, the next step is a conversation with a doctor.
Find out if you qualify for GLP-1 peptide treatment in Singapore.
Book ConsultationThis article is for informational purposes only and does not constitute medical advice. Always consult your doctor before starting, stopping, or changing any medication. Individual results may vary. Trimly is a MOH-licensed telehealth clinic in Singapore (HCSA License R/25M0505/MDS/001/252). Clinical trial results are based on controlled study conditions and may not reflect real-world outcomes. Weight loss results vary depending on individual factors including starting weight, adherence, diet, and exercise. The figures cited in this article come from specific trial populations and dosing regimens.